Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus
- PMID: 12414910
- DOI: 10.1210/jc.2002-020486
Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus
Abstract
To clarify whether homeostasis model assessment (HOMA IR) and quantitative insulin sensitivity check index (QUICKI) may be indicators of insulin resistance in elderly patients with type 2 diabetes mellitus, their relationship with the glucose infusion rate during the euglycemic hyperinsulinemic clamp study (clamp IR) was assessed. This study comprised 56 Japanese patients with type 2 diabetes mellitus; of these, 28 were 70 yr of age or older (group 1) and 28 were less than 70 yr of age (group 2). Their blood sugars were in poor control (fasting plasma glucose levels: group 1, 9.0 +/- 2.6 mmol/liter; group 2, 8.9 +/- 2.3 mmol/liter; hemoglobin A1c: group 1, 9.5 +/- 2.0%; group 2, 9.2 +/- 1.7%). Log-transformed HOMA IR was significantly correlated with the clamp IR in group 2 patients (r = -0.51, P < 0.01), but not in group 1 patients (r = -0.28, P = 0.15). There was a significant positive correlation between QUICKI and clamp IR in group 2 patients (r = 0.50, P < 0.01). However, no significant correlation was observed between QUICKI and clamp IR in group 1 patients (r = 0.31, P = 0.12). There was a significant correlation between log-transformed HOMA IR (r = -0.37, P < 0.01) or QUICKI (r = 0.37, P < 0.01) and clamp IR when both groups were combined. In conclusion, neither HOMA IR nor QUICKI should be used as an index of insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. The results of this study suggest the need for developing a new noninvasive method for evaluating insulin resistance in those patients.
Similar articles
-
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.J Clin Endocrinol Metab. 2004 Mar;89(3):1481-4. doi: 10.1210/jc.2003-031374. J Clin Endocrinol Metab. 2004. PMID: 15001651
-
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.Diabetes Care. 2003 Aug;26(8):2426-32. doi: 10.2337/diacare.26.8.2426. Diabetes Care. 2003. PMID: 12882874 Clinical Trial.
-
Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.Diabetes Care. 2001 Feb;24(2):362-5. doi: 10.2337/diacare.24.2.362. Diabetes Care. 2001. PMID: 11213893
-
Effect of Inulin-Type Carbohydrates on Insulin Resistance in Patients with Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis.J Diabetes Res. 2019 Aug 27;2019:5101423. doi: 10.1155/2019/5101423. eCollection 2019. J Diabetes Res. 2019. PMID: 31534973 Free PMC article.
-
Exploring effects of melatonin supplementation on insulin resistance: An updated systematic review of animal and human studies.Diabetes Metab Syndr. 2024 Jul;18(7):103073. doi: 10.1016/j.dsx.2024.103073. Epub 2024 Jul 23. Diabetes Metab Syndr. 2024. PMID: 39096757
Cited by
-
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.J Gastroenterol. 2007 Jul;42(7):573-82. doi: 10.1007/s00535-007-2060-x. Epub 2007 Jul 25. J Gastroenterol. 2007. PMID: 17653654
-
Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice.J Inflamm Res. 2021 Jul 9;14:3089-3105. doi: 10.2147/JIR.S320451. eCollection 2021. J Inflamm Res. 2021. PMID: 34276223 Free PMC article.
-
Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study.Diabetes Care. 2013 Jun;36(6):1512-21. doi: 10.2337/dc12-1017. Epub 2012 Dec 28. Diabetes Care. 2013. PMID: 23275371 Free PMC article.
-
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.Cardiovasc Diabetol. 2023 Sep 16;22(1):251. doi: 10.1186/s12933-023-01964-8. Cardiovasc Diabetol. 2023. PMID: 37716952 Free PMC article.
-
To: Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia 47:1557-1565.Diabetologia. 2005 Jul;48(7):1427-8; author reply 1429. doi: 10.1007/s00125-005-1783-6. Epub 2005 Jun 3. Diabetologia. 2005. PMID: 15933862 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical